Cardiology Emergency Medicine Strong — derived and validated in >89,000 NSTEMI patients
CRUSADE Bleeding Risk Score
Estimates the risk of in-hospital major bleeding in patients with NSTEMI/ACS. Considers haematocrit, creatinine clearance, heart rate, sex, signs of heart failure, prior vascular disease, diabetes, and SBP.
References
- Subherwal S, et al. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE Bleeding Score. Circulation. 2009;119(14):1873–1882.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Bivalirudin (PCI Anticoagulation) · Direct Thrombin Inhibitor / PCI
- Vasopressin / Terlipressin · Vasopressin Analogue — Vasodilatory Shock / Variceal Bleeding
- Bivalirudin · Anticoagulation
- Tranexamic Acid (Heavy Menstrual Bleeding) · Antifibrinolytic (Gynaecological Use)
- Palivizumab · RSV Prophylaxis — Monthly Monoclonal Antibody (High-Risk Infants)
- Ziprasidone · Atypical Antipsychotic — D2/5-HT2A Antagonist (Low Metabolic Risk)
Pathways
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.